AiCure recently launched a digital tool that detects subtle changes in a patient’s condition that can be used to enrich data generated in clinical trials.
AiCure is an AI and advanced data analytics company targeting the health care industry. AiCure uses artificial intelligence to see, hear and understand how people respond to treatment across clinical trials and patient care. Clinically proven to accurately measure and modify patient behavior, AiCure’s technologies keep patients engaged and optimized to treatment, as well as assess treatment effectiveness.
AiCure, using a patient’s own smartphone camera, the app remotely detects visual, auditory and behavioral changes that could indicate whether or not a patient is responding to treatment, or suffering side effects.
It asks the patient simple questions or has them complete brief tasks, and then uses AI to analyze behavior, such as response time, effect, physical movement and speech patterns. AiCure’s interactive medical assistant, or IMA, can also detect if patients are at higher risk of dropping out of a trial because they are not adhering to treatment.
AiCure, building on its successful results in 2019, remains focused on helping pharmaceutical and biotech companies leverage different applications of artificial intelligence to accelerate drug development, addressing two main challenges: outdated measures of adherence and a poor understanding of patient response to treatment.
AiCure’s 2019 revenues grew 65% over 2018 revenue and the company set a record pace of new customer acquisition with the addition of 13 new pharmaceutical and biotechnology companies. AiCure doubled the number of deployments contracted and supported clinical trial programs within 16 new countries.
AiCure also developed a relationship with Syneos Health®, announcing Syneos as the first mover participant in its AiCure Partnerships for Excellence (AiPEX™) program – a novel strategic contract research organization (CRO) partnership to drive faster, smarter trials to optimize patient engagement.
Takeaway: AiCure remains focused on helping pharmaceutical and biotech companies leverage different applications of artificial intelligence